LeBlanc EV, Kim Y, Capicciotti CJ, Colpitts CC. Hepatitis C Virus Glycan-Dependent Interactions and the Potential for Novel Preventative Strategies. Pathogens 2021;10:685. [PMID: 34205894 DOI: 10.3390/pathogens10060685][Reference Citation Analysis]
Badami E, Carcione C, Chinnici CM, Tinnirello R, Conaldi PG, Iannolo G. HCV Interplay With Mir34a: Implications in Hepatocellular Carcinoma. Front Oncol 2022;11:803278. [DOI: 10.3389/fonc.2021.803278][Reference Citation Analysis]
4
Macek Jilkova Z, Saleem K, Afzal S, Decaens T. Predictive Factors for Hepatocellular Carcinoma Development after Direct-Acting Antiviral Treatment of HCV. Livers 2021;1:313-21. [DOI: 10.3390/livers1040024][Cited by in Crossref: 1][Article Influence: 1.0][Reference Citation Analysis]
5
Chan MH, Lu CN, Chung YL, Chang YC, Li CH, Chen CL, Wei DH, Hsiao M. Magnetically guided theranostics: montmorillonite-based iron/platinum nanoparticles for enhancing in situ MRI contrast and hepatocellular carcinoma treatment. J Nanobiotechnology 2021;19:308. [PMID: 34627267 DOI: 10.1186/s12951-021-01052-7][Cited by in Crossref: 1][Article Influence: 1.0][Reference Citation Analysis]